2025 International Conference - Insights
For more than 40 years, this meeting has been the major international conference in Lyme disease and other tick-borne infections, bringing together the most knowledgeable investigators in the world and their trainees to share scientific...
2025 International Conference - Insights
For more than 40 years, this meeting has been the major international conference in Lyme disease and other tick-borne infections, bringing together the most knowledgeable investigators in the world and their trainees to share scientific...
2025 International Conference - Insights
For more than 40 years, this meeting has been the major international conference in Lyme disease and other tick-borne infections, bringing together the most knowledgeable investigators in the world and their trainees to share scientific...
2025 International Conference - Insights
For more than 40 years, this meeting has been the major international conference in Lyme disease and other tick-borne infections, bringing together the most knowledgeable investigators in the world and their trainees to share scientific...
2025 International Conference - Insights
For more than 40 years, this meeting has been the major international conference in Lyme disease and other tick-borne infections, bringing together the most knowledgeable investigators in the world and their trainees to share scientific...
2025 International Conference - Insights
For more than 40 years, this meeting has been the major international conference in Lyme disease and other tick-borne infections, bringing together the most knowledgeable investigators in the world and their trainees to share scientific...
07/2023© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Abacavir Hypersensitivity Testing and Initial Patient Management Algorithm 1. Saag M, Balu R, Phillips E, et al. High sensitivity of human...
New Eligibility Guidelines for Blood Donors with Previous Cancer Diagnoses - Insights
To coincide with American Red Cross recommendations, the Mayo Clinic Blood Donor Program has redefined eligibility guidelines for donors who have had a history of previous cancer diagnoses.
Bobbi Pritt, M.D., and Matthew Binnicker, Ph.D., offered insight on testing accuracy, as well as circumstances that could affect a test's reliability.
Find out why testing for anti-neutrophil cytoplasmic and anti-glomerular basement membrane antibodies is recommended for differential diagnosis.